43 episodes

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

PeerVoice Immunology & Infectious Disease Audio PeerVoice

    • Science

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

    GP Empowerment: Eliminating HCV From the Front Line

    GP Empowerment: Eliminating HCV From the Front Line

    Visit https://www.peervoice.com/JBJ860 to view the entire programme with slides. After completing “GP Empowerment: Eliminating HCV From the Front Line”, participants will be able to: Formulate tailored treatment plans for patients with hepatitis C virus (HCV), depending on patient and disease factors; Use patient-physician communication about HCV and its treatment as a tool to improve patient identification; Apply evidence-based therapies to optimise sustained virological response rates and patient quality of life.

    • 29 min
    If You Suspect, Test! The Important First Steps to Preventing the Devastating Consequences of Hepatitis

    If You Suspect, Test! The Important First Steps to Preventing the Devastating Consequences of Hepatitis

    Visit https://www.peervoice.com/TWY860 to view the entire programme with slides. After completing “If You Suspect, Test! The Important First Steps to Preventing the Devastating Consequences of Hepatitis”, participants will be able to: Recognise the need for routine screening for HCV/HBV infection; Apply practical strategies for HCV/HBV screening; Formulate patient-centred approaches for communicating with patients about the need for HCV/HBV screening.

    • 19 min
    Can Long-Acting Injectables Make a Difference in HIV?

    Can Long-Acting Injectables Make a Difference in HIV?

    Visit https://www.peervoice.com/VXE860 to view the entire programme with slides. After completing “Can Long-Acting Injectables Make a Difference in HIV?”, participants will be able to: Evaluate the clinical evidence for long-acting injectable therapy for people living with HIV (PLWH); Summarise the potential benefits and limitations of daily vs long-acting therapy in the long-term management of HIV; Create individualised management strategies for therapy for PLWH, taking into account patient needs.

    • 25 min
    Optimising HBV Treatment Outcomes Whilst We Hunt for a Cure

    Optimising HBV Treatment Outcomes Whilst We Hunt for a Cure

    Visit https://www.peervoice.com/KYP860 to view the entire programme with slides. After completing “Optimising HBV Treatment Outcomes Whilst We Hunt for a Cure”, participants will be able to: Identify the importance of reducing hepatocellular carcinoma (HCC) risk and improving secondary outcomes in patients receiving viral suppressive therapy; Recognise that antiviral suppressive therapies may differ in their impact on HCC risk and secondary outcomes; Describe the latest data for suppressive therapies and their potential impact on treatment strategies.

    • 17 min
    Opportunistic Invasive Fungal Infections: Proactive Diagnosis of Patients at Risk

    Opportunistic Invasive Fungal Infections: Proactive Diagnosis of Patients at Risk

    Visit https://www.peervoice.com/QVJ860 to view the entire programme with slides. After completing “Opportunistic Invasive Fungal Infections: Proactive Diagnosis of Patients at Risk”, participants will be able to: Discuss the importance of increasing early recognition and diagnosis of invasive fungal infections (IFI) in patients at increased risk of infection; Identify the risk factors, clinical signs, and symptoms that would increase the index of suspicion of an IFI; Apply appropriate diagnostic and radiologic tests needed to confirm the type of IFI.

    • 23 min
    Practical Strategies in Optimising Subcutaneous Immunoglobulin Replacement Therapy

    Practical Strategies in Optimising Subcutaneous Immunoglobulin Replacement Therapy

    Visit https://www.peervoice.com/MXF860 to view the entire programme with slides. After completing “Practical Strategies in Optimising Subcutaneous Immunoglobulin Replacement Therapy”, participants will be able to: Recognise the differences between the clinical profiles of each Ig replacement modality; Describe the appropriate Ig modality based on patient preference and clinical criteria; Anticipate adverse reactions and side effects associated with subcutaneous Ig use and develop appropriate strategies to manage or avoid them.

    • 1 hr 1 min

Top Podcasts In Science

Listeners Also Subscribed To

More by PeerVoice